Global Cancer Biomarkers Market 2017-2024 Analysis and Trends Expected to Reach at a CAGR of 12.2%markets report “Global Cancer Biomarkers Market” has accounted to USD 10.9 billion in 2016, growing at a CAGR of 12.2% from 2017 to 2024, and is expected to reach USD 27.4 billion by 2024.
Global Cancer Biomarkers Market, By Tumor (Breast, Lung, Prostate), By Type (Protein Biomarker, Genetic Biomarkers), By Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), By Application (Diagnostic, Drug Discovery, Prognostic), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024
Ask for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-biomarkers-market
Cancer biomarkers are the molecules secreted by a tumor or a specific response of the human body indicating the presence of cancer. The biomarkers enable cancer detection at an early stage and facilitate high-speed noninvasive diagnosis using various genomics and proteomics tools. Cancer biomarkers are used for various applications such as cancer diagnostics, drug discovery and development, prognostics, personalized medicine, and surrogate endpoints. Over the years, cancer biomarkers have become an integral part of research in pharmaceutical and clinical trial companies, as they help to reduce the time and cost of the drug discovery and development process.
Major Factors of Global Cancer Biomarkers Market:
Factors such as rising prevalence of cancer, increasing government support for cancer biomarkers research, rising aging population, increasing use of biomarkers in the drug discovery and development process, and increasing use of biomarker tests for diagnosis purposes are fueling the growth of this market. However, poorly suited regulatory and reimbursement systems and high capital investments required for biomarker development and validation are the major factors restraining the growth of this market. Cancer biomarkers’ research and development is highly capital intensive; this is one of the key entry barriers for new players willing to enter the cancer biomarkers market. Majority of the biomarker development studies receive funding from government organizations or large pharmaceutical companies.
Speak to Analyst about Global Cancer Biomarkers Market Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cancer-biomarkers-market
In this report, the cancer biomarkers market is segmented on the basis of type, cancer type, profiling technology, application, and geography.
Based on type, the cancer biomarkers market is broadly split into three segments, namely, protein biomarkers, genetic biomarkers, and other biomarkers (includes viral, cell, and carbohydrate biomarkers). In 2015, the protein biomarkers segment accounted for the largest share of the global cancer biomarkers market. The large share of this segment is mainly attributed to the tremendous potential of protein biomarkers in cancer detection, diagnostics, prognostics, and clinical & therapeutic applications; and low cost of the protein biomarker tests as compared to genetic biomarker tests. The increasing focus of pharmaceutical companies towards the discovery of protein biomarkers is further expected to fuel the growth of this market in the coming years.
Based on cancer type, the cancer biomarkers market is categorized into breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, and other cancers (includes melanoma, leukemia, gastric, kidney, liver, and pancreatic cancers).
The cancer biomarkers market, by profiling technology, is segmented into omics technologies, imaging technologies, immunoassays, cytogenetics, and bioinformatics. The omics technologies segment accounted for the largest share of the global cancer biomarkers market in 2015. The largest share of this segment is mainly attributed to the increased adoption of advanced high throughput technologies in biomarker discovery and development and increasing use of omics-based tests for cancer diagnosis and drug development process. Omics technologies also represent the fastest-growing cancer biomarkers segment. The high growth rate of this segment can be attributed to the increasing adoption of advanced omics technologies for cancer detection and drug discovery & development applications, specifically in developing countries. Advances in high-throughput omics technologies are also contributing to the growth of this market, by increasing the space of prospective biomarkers in cancer research.
Read more about the Global Cancer Biomarkers Market Report Visit @ http://databridgemarketresearch.com/reports/global-cancer-biomarkers-market/
Based on geography the global cancer biomarkers market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
Some of the major players operating in the global cancer biomarkers market are Abbott Laboratories, DiagnoCure Inc., Affymetrix, Inc., Illumina, Inc., Qiagen N.V., Roche Diagnostics Ltd., Agilent Technologies Inc., Quest Diagnostics Inc., Merck & Co. Inc., Hologic, Inc., and Becton Dickinson and Company among others.
Global Radiopharmaceuticals Market – Industry Trends and Forecast to 2024
Global Radiopharmaceuticals Market, By Type (Diagnostic, Therapeutic), Procedural Volumes (Diagnostic Procedures, Therapeutic Procedures), Application, Sources (Nuclear Reactors, Cyclotrons), End User, Geography (North America, Europe, APAC, South America, MEA)– Industry Trends andForecast To 2024
Report Access: http://databridgemarketresearch.com/reports/pharmaceutical/global-radiopharmaceuticals-market-trends-forecast-2024/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cancer Biomarkers Market 2017-2024 Analysis and Trends Expected to Reach at a CAGR of 12.2% here
News-ID: 738503 • Views: 359
More Releases from Data Bridge Market Research
Graphene Market Market a healthy CAGR of 42.16% in the forecast 2019-2026 Top Ke …
Market Analysis: Global Graphene Market Global Graphene Market is expected to rise to an estimated value by registering a healthy CAGR of 42.16% in the forecast period of 2019-2026. Increasing investment in graphene production and rising collaborations between industries are the factor for the growth of this market. Fill Out Details to Receive FREE Sample Report Copy Here https://databridgemarketresearch.com/request-a-sample/?dbmr=global-graphene-market Graphene is a highly conductive allotrope which consists of single layer of carbon
Activated Carbon Market 2019 Global Trends, Growth and Forecast 2026 Top Key Ana …
In depth analysis of the Market Global Activated Carbon Market is expected to register a healthy CAGR of 10.08% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the increasing usage of the product in different purification and treatment processing in different industries. Activated carbon is a carbonaceous, highly
Portable Gas Detectors Market Growth by 2026 Global Market Analysis, Size, Share …
Portable Gas Detectors Market report analyses and presents the historic data along with the current performance of the market. The emerging trends along with major drivers, challenges and opportunities in the market are also identified and analyzed in this report. The report really serves to be a proven solution for businesses to gain a competitive advantage. Portable Gas Detectors Market report contains information about historic data, present market trends, environment,
Wireless LAN Controller Market 2019 Global key Players D-Link Corporation Huawei …
Market Analysis: Global Wireless LAN Controller Market Global Wireless LAN Controller Market is expected to rise to an estimated value of USD 3.03 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the rapid rise of wireless connectivity and infrastructural requirement. A WLAN is a wireless Industry architecture that aims to meet changing network demands. A WLAN controller manages
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and